PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions - Top-Institutions - MDSpire

PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions

  • By

  • Jeremy Kwe

  • Martin Baunacke

  • Katharina Boehm

  • Ivan Platzek

  • Christian Thomas

  • Angelika Borkowetz

  • February 16, 2024

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Radiology
    • Oncology

  • #2

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Urology
    • Radiology
    • Cancer Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Radiology

  • #4

    Technische Universität Dresden, University Hospital Carl Gustav Carus
    Technische Universität Dresden, University Hospital Carl Gustav Carus

    Dresden, Saxony

    Key Differentiators

    • Urology
    • Radiology

  • #5

    University of Cambridge, Addenbrooke's Hospital
    University of Cambridge, Addenbrooke's Hospital

    Cambridge, Cambridgeshire

    Key Differentiators

    • Urology
    • Radiology

Original Source(s)

PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions

  • by Jeremy Kwe, Martin Baunacke, Katharina Boehm, Ivan Platzek, Christian Thomas, Angelika Borkowetz

  • February 16, 2024

Related Content

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging

Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project

Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors